Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Antiviral Therapy|February 2, 2012
Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapyCarole L Wallis, Maria A Papathanasopolous, Matthew Fox, et al.
The Lancet. Respiratory Medicine|July 14, 2018
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort studyKathryn Schnippel, Norbert Ndjeka, Gary Maartens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2009
Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapyDaniel J Westreich, Ian Sanne, Mhairi Maskew, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfectionFrancesca Conradie, Andrea S Foulkes, Prudence Ive, et al.
The New England Journal of Medicine|June 24, 2026
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant TuberculosisFrancesca Conradie, Tasnim Badat, Asanda Poswa, et al.
Southern African Journal of HIV Medicine|March 24, 2018
Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapyGraeme Meintjes, John Black, Francesca Conradie, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 19, 2025
Development and validation of an LC-MS/MS multiplex assay for the quantification of bedaquiline, n-desmethyl bedaquiline, linezolid, levofloxacin, and clofazimine in dried blood spotsGerard Aime Kenfack Teponnou, Anton Joubert, Saskia Spaltman, et al.
Pageof 7